Current guidelines recommend severity of chronic obstructive pulmonary disease be graded by using forced expiratory volume in 1 s (FEV1). But this measurement is biased by thoracic gas compression depending on lung volume and airflow resistance. The aim of this study was to test the hypothesis that the effect of thoracic gas compression on FEV1 is greater in emphysema than chronic bronchitis because of larger lung volumes, and this influences severity classification and prognosis. FEV1 was simultaneously measured by spirometry and body plethysmography (FEV1-p1) in 47 subjects with dominant emphysema and 51 with dominant chronic bronchitis. Subjects with dominant emphysema had larger lung volumes, lower diffusion capacity, and lower FEV1 than those with dominant chronic bronchitis. However, FEV1-p1, patient-centered variables (dyspnea, quality of life, exercise tolerance, exacerbation frequency), arterial blood gases, and respiratory impedance were not significantly different between groups. Using FEV1-p1 instead of FEV1 shifted severity distribution toward less severe classes in dominant emphysema more than chronic bronchitis. The body mass, obstruction, dyspnea, and exercise (BODE) index was significantly higher in dominant emphysema than chronic bronchitis, but this difference significantly decreased when FEV1-p1 was substituted for FEV1. In conclusion, the FEV1 is biased by thoracic gas compression more in subjects with dominant emphysema than in those with chronic bronchitis. This variably and significantly affects the severity grading systems currently recommended.

Severity grading of chronic obstructive pulmonary disease : the confounding effect of phenotype and thoracic gas compression / R. Pellegrino, E. Crimi, A. Gobbi, R. Torchio, A. Antonelli, C. Gulotta, M. Baroffio, G.F. Sferrazza Papa, R. Dellacà, V. Brusasco. - In: JOURNAL OF APPLIED PHYSIOLOGY. - ISSN 8750-7587. - 118:7(2015 Apr), pp. 796-802.

Severity grading of chronic obstructive pulmonary disease : the confounding effect of phenotype and thoracic gas compression

G.F. Sferrazza Papa;
2015

Abstract

Current guidelines recommend severity of chronic obstructive pulmonary disease be graded by using forced expiratory volume in 1 s (FEV1). But this measurement is biased by thoracic gas compression depending on lung volume and airflow resistance. The aim of this study was to test the hypothesis that the effect of thoracic gas compression on FEV1 is greater in emphysema than chronic bronchitis because of larger lung volumes, and this influences severity classification and prognosis. FEV1 was simultaneously measured by spirometry and body plethysmography (FEV1-p1) in 47 subjects with dominant emphysema and 51 with dominant chronic bronchitis. Subjects with dominant emphysema had larger lung volumes, lower diffusion capacity, and lower FEV1 than those with dominant chronic bronchitis. However, FEV1-p1, patient-centered variables (dyspnea, quality of life, exercise tolerance, exacerbation frequency), arterial blood gases, and respiratory impedance were not significantly different between groups. Using FEV1-p1 instead of FEV1 shifted severity distribution toward less severe classes in dominant emphysema more than chronic bronchitis. The body mass, obstruction, dyspnea, and exercise (BODE) index was significantly higher in dominant emphysema than chronic bronchitis, but this difference significantly decreased when FEV1-p1 was substituted for FEV1. In conclusion, the FEV1 is biased by thoracic gas compression more in subjects with dominant emphysema than in those with chronic bronchitis. This variably and significantly affects the severity grading systems currently recommended.
Chronic bronchitis; Emphysema; Forced expiratory volume in 1 s; Plethysmography; Algorithms; Diagnosis, Computer-Assisted; Humans; Lung; Middle Aged; Phenotype; Plethysmography, Whole Body; Pulmonary Disease, Chronic Obstructive; Reproducibility of Results; Respiratory Function Tests; Sensitivity and Specificity; Total Lung Capacity; Artifacts; Severity of Illness Index; Physiology; Physiology (medical)
Settore MED/10 - Malattie dell'Apparato Respiratorio
apr-2015
Article (author)
File in questo prodotto:
File Dimensione Formato  
RP JAP 2015.full.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 160.32 kB
Formato Adobe PDF
160.32 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/469224
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 15
social impact